Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04045964 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT04045964 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 32 participants.
The verdict
NCT04045964, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.
Interventions
- DRUG nicotine replacement therapy (NRT)
- BEHAVIORAL motivational advice
- BEHAVIORAL Quitline referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-10-29 |
| Est. Completion | 2018-06-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04045964
The ClinicalTrials.gov registry entry for NCT04045964 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which nicotine replacement therapy (NRT) is the first listed.
NCT04045964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04045964 about?
NCT04045964 is a clinical study titled "Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families". The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.
What is the current status of trial NCT04045964?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2017-10-29. Estimated completion is 2018-06-28.
What interventions are being tested in trial NCT04045964?
The interventions under investigation include: nicotine replacement therapy (NRT) (DRUG), motivational advice (BEHAVIORAL), Quitline referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT04045964?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.